Iyer SP, Huen A, Ai WZ, Jagadeesh D, et al. Safety and efficacy of tenalisib in combination with romidepsin in patients with relapsed/refractory T-cell lymphoma: results from a phase I/II open-label multicenter study. Haematologica 2023 Jul 13. doi: 10.3324/haematol.2022.281875.
PMID: 37439343